A4TVL0 (A4TVL0_9PROT) Magnetospirillum gryphiswaldense
Cereblon isoform 4 UniProtKBInterProInteractive Modelling
124 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
54 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex a long aspartimide degron pepti… |
Heteromer P05067; | 1×ZN; | ||||
Assess | ||||||
Cereblon isoform 4 in complex with novel Benzamide-Type Cereblon Binder 8d | homo-3-mer | 3×ZN; 2×EF2; 3×PO4; 1×W1T; | ||||
Assess | ||||||
Cereblon isoform 4 in complex with novel Benzamide-Type Cereblon Binder 11e | homo-3-mer | 3×ZN; 3×W1B; | ||||
Assess | ||||||
Cereblon isoform 4 in complex with novel Benzamide-Type Cereblon Binder 11f | homo-3-mer | 3×ZN; 2×W0Z; 1×PO4; | ||||
Assess | ||||||
Cereblon isoform 4 in complex with novel Benzamide-Type Cereblon Binder 11b | homo-3-mer | 3×ZN; 2×W1X; | ||||
Assess | ||||||
Cereblon isoform 4 in complex with novel Benzamide-Type Cereblon Binder 11c | homo-3-mer | 3×ZN; 2×W26; 4×PO4; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with compound 16b | monomer | 1×ZN; 1×EF2; 1×PO4; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with compound 20b | monomer | 1×ZN; 1×EF2; 1×PO4; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with compound 11a | monomer | 1×ZN; 1×EF2; 1×PO4; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with compound 20a | monomer | 1×ZN; 1×EF2; 1×PO4; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with Deoxyuridine | monomer | 1×ZN; 1×DUR; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with compound 12a | monomer | 1×ASP; 1×ZN; 1×EF2; 1×PO4; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with hydrolysis product of comp… | monomer | 1×ZN; 1×JO2; 3×PO4; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with compound 4a and hydrolysis… | monomer | 1×ZN; 1×EF2; 1×PO4; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with compound 5a and hydrolysis… | monomer | 1×ZN; 1×EF2; 1×PO4; 1×CL; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with compound 7b | monomer | 1×ZN; 1×EF2; 1×PO4; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with compound 5b | monomer | 1×ZN; 1×JOB; 1×PO4; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with Avadomide (CC-122) | monomer | 1×ZN; 1×EF2; 1×PO4; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with spiro-isoxazol based compo… | monomer | 1×ZN; 1×A1HZ3; 1×PO4; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with compound 7f | monomer | 1×ZN; 1×EF2; 1×PO4; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex an aminoglutarimide degron pept… | monomer | 1×ZN; 1×EF2; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex an aspartimide degron peptide | monomer | 1×ZN; 3×PO4; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with Iberdomide (CC-220) | monomer | 1×ZN; 1×8W7; | ||||
Assess | ||||||
Mutant cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with thalidomide metabol… | monomer | 1×ZN; 1×JNW; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with Thalidomide, Wash II struc… | monomer | 1×ZN; 1×EF2; 2×PO4; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with spiro-isoxazol based compo… | monomer | 1×ZN; 1×A1HZ7; 1×NA; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with compound 7d, co-crystalliz… | monomer | 1×ZN; 1×JP5; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with Thalidomide, trigonal crys… | monomer | 1×ZN; 1×EF2; 1×CA; 7×CL; 1×NI; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with Thiazolidine-2,4-dione | monomer | 1×ZN; 1×9UT; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with Piperidin-2-one (Valerolac… | monomer | 1×ZN; 1×V1L; | ||||
Assess | ||||||
Bacterial cereblon homologue in complex with (R)-3-(4-methoxyphenyl)piperidine-2,6-dione | monomer | 1×ZN; 1×9FT; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with Thalidomide | monomer | 1×ZN; 1×EF2; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with Pomalidomide | monomer | 1×ZN; 1×Y70; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with 2-Thiohydantoin | monomer | 1×ZN; 1×9UW; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with Aminoglutethimide | monomer | 1×ZN; 1×EF2; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with Lenalidomide | monomer | 1×ZN; 1×LVY; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with Imidazolidine-2,4-dione (H… | monomer | 1×ZN; 1×HYN; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with Pyrrolidin-2-one (Butyrola… | monomer | 1×ZN; 1×BAQ; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with Thalidomide, Y101F mutant | monomer | 1×ZN; 1×EF2; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with compound 14r | monomer | 1×ZN; 1×MW6; 1×PO4; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with Rolipram | monomer | 1×ZN; 1×ROL; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with a benzotriazole analog of … | monomer | 1×ZN; 1×7SE; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with compound 20a | monomer | 1×ZN; 1×N8F; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with Ethosuximide | monomer | 1×ZN; 1×9V2; | ||||
Assess | ||||||
Cereblon isoform 4 in complex with novel Benzamide-Type Cereblon Binder 11a | monomer | 1×ZN; 1×W2F; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with Piperidine-2,6-dione (Glut… | monomer | 1×ZN; 1×9UZ; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in multiple conformations, hexagonal cryst… | monomer | 1×ZN; 1×EF2; | ||||
Assess | ||||||
Cereblon isoform 4 in complex with novel Benzamide-Type Cereblon Binder 11d | monomer | 1×ZN; 1×W1F; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with Thalidomide, Wash I struct… | monomer | 1×ZN; 1×EF2; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with compound 7a | monomer | 1×ZN; 1×JPQ; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with compound 7c | monomer | 1×ZN; 1×JPB; 1×PO4; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with spiro-isoxazol based compo… | monomer | 1×ZN; 1×YQO; 1×PO4; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with spiro-isoxazol based compo… | monomer | 1×ZN; 1×A1HZ2; 1×PO4; | ||||
Assess | ||||||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with spiro-isoxazol based compo… | monomer | 1×ZN; 1×A1HZ6; 1×PO4; | ||||
Assess |
1 SWISS-MODEL model
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
7ps9.1.A | monomer | 0.84 | 1×ZN; 1×8W7; | 100.00 | ||
Assess |